Login / Signup

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.

Juan F ArturoBoris I ChobrutskiyMichelle YeagleyDhruv N PatelShayan FalasiriJay S PatelGeorge Blanck
Published in: Cellular & molecular immunology (2019)
Keyphrases
  • free survival
  • amino acid
  • wild type
  • binding protein
  • breast cancer risk